• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bed Bath & Beyond Shares Are Trading Lower By Around 24%? Here Are Other Stocks Moving In Monday's Mid-Day Session

    3/20/23 2:18:52 PM ET
    $ABR
    $ACER
    $ACRV
    $ALLR
    Real Estate Investment Trusts
    Real Estate
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ABR alert in real time by email

    Gainers

    • Loyalty Ventures Inc. (NASDAQ:LYLT) gained 121.1% to $0.19. Shares of companies in the broader communication, media & entertainment industry traded higher as stocks rebound from recent weakness stemming from instability concerns in the financial sector, which could impact future Fed policy.
    • Gelesis Holdings, Inc. (NYSE:GLS) gained 82.7% to $0.2010.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 72.5% to $0.1812 after the company said it dosed the first patient in its trial studying advanced solid tumors.
    • Ambipar Emergency Response (NYSE:AMBI) shares climbed 60.5% to $13.18.
    • Lifecore Biomedical, Inc. (NASDAQ:LFCR) gained 60% to $2.67. Lifecore Biomedical, on Friday, reported worse-than-expected Q2 financial results.
    • Acer Therapeutics Inc. (NASDAQ:ACER) jumped 55% to $1.04. EF Hutton reiterated Acer Therapeutics with a Buy and maintained a $7 price target.
    • Biocept, Inc. (NASDAQ:BIOC) gained 47.2% to $0.3472. Biocept engaged a financial advisor to explore strategic alternatives.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) jumped 46% to $1.54.
    • Boxed, Inc. (NASDAQ:BOXD) climbed 43% to $0.1447.
    • New York Community Bancorp, Inc. (NASDAQ:NYCB) gained 40% to $9.18 after the Federal Deposit Insurance Corporation (FDIC) announced NYCB subsidiary Flagstar Bank entered into a purchase agreement for Signature Bridge Bank. Multiple analysts upgraded the stock in the wake of the announcement.
    • Sonim Technologies, Inc. (NASDAQ:SONM) gained 31% to $0.5506.
    • Gossamer Bio, Inc. (NASDAQ:GOSS) jumped 27.5% to $1.2250. Gossamer Bio, on Friday, posted a Q4 loss of $0.59 per share.
    • Tempo Automation Holdings, Inc. (NASDAQ:TMPO) gained 27% to $0.61.
    • Golden Minerals Company (NYSE:AUMN) rose 27% to $0.2578.
    • FG Financial Group, Inc. (NASDAQ:FGF) gained 23.7% to $2.50.
    • SuRo Capital Corp. (NASDAQ:SSSS) shares climbed 19.1% to $3.49. SuRo Capital will commence a modified Dutch Auction tender offer to repurchase up to 3 million shares of its common stock.
    • Lavoro Limited (NASDAQ:LVRO) gained 17.1% to $8.09.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) rose 15% to $14.40.
    • Genelux Corporation (NASDAQ:GNLX) gained 12.9% to $30.82.
    • Franchise Group, Inc. (NASDAQ:FRG) jumped 11.8% to $25.44. Franchise Group revealed the receipt of an unsolicited non-binding proposal to acquire all of its outstanding shares at $30.00 per share in cash.
    • Talos Energy Inc. (NYSE:TALO) gained 10.8% to $13.17 after the company announced a $100 million share repurchase authorization.
    • PacWest Bancorp (NASDAQ:PACW) gained 10.1% to $10.22 after the company provided an update on its liquidity position.
    • Sigma Lithium Corporation (NASDAQ:SGML) climbed 9.6% to $36.49.
    • UMB Financial Corporation (NASDAQ:UMBF) rose 8.8% to $ 63.40.
    • Arbor Realty Trust, Inc. (NYSE:ABR) gained 8.8% to $12.18.
    • iStar Inc. (NYSE:STAR) climbed 8.2% to $7.30.
    • OSI Systems, Inc. (NASDAQ:OSIS) gained 8% to $98.42. OSI Systems secured an award valued at $600 million, which includes 16% value added tax (VAT), from Mexico's Secretaría de la Defensa Nacional (SEDENA) for cargo and vehicle inspection systems and related services.
    • BankUnited, Inc. (NYSE:BKU) gained 6.8% to $22.70.
    • Value Line, Inc. (NASDAQ:VALU) gained 6.7% to $49.47. Value Line recently reported Q3 earnings.
    • FLEETCOR Technologies, Inc. (NYSE:FLT) gained 5.8% to $198.11 after the company announced it entered into a cooperation agreement with the D.E. Shaw Group and also agreed to form an ad hoc Strategic Review Committee.

    Losers

    • Aziyo Biologics, Inc. (NASDAQ:AZYO) fell 57.4% to $1.66 after the company received a determination from the FDA indicating that the company's premarket notification for the CanGaroo RM Antibacterial Envelope is not substantially equivalent.
    • Credit Suisse Group AG (NYSE:CS) shares dipped 52.9% to $0.9465 after UBS agreed to acquire the bank for $3.2 billion.
    • CXApp Inc. (NASDAQ:CXAI) fell 33% to $1.92.
    • Sunlight Financial Holdings Inc. (NYSE:SUNL) fell 32.8% to $0.2865.
    • Acrivon Therapeutics, Inc. (NASDAQ:ACRV) dropped 31% to $13.80.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) fell 24.4% to $0.2950. Pear Therapeutics said it is exploring strategic alternatives and said it may seek a reorganization if it is unable to complete a transaction. Credit Suisse, TD Cowen and Chardan Capital downgraded the stock.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) dropped 23.6% to $0.7859 after the company announced a special shareholder meeting to approve a 1-for-5 to 1-for-10 reverse stock split.
    • Bakkt Holdings, Inc. (NASDAQ:BKKT) fell 23.3% to $1.32
    • Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) dropped 23% to $0.2385.
    • Codiak BioSciences, Inc. (NASDAQ:CDAK) fell 23% to $0.4675.
    • Omega Therapeutics, Inc. (NASDAQ:OMGA) dropped 21.9% to $7.64.
    • SOPHiA GENETICS SA (NASDAQ:SOPH) dipped 20.7% to $4.32.
    • Home Point Capital Inc. (NASDAQ:HMPT) fell 20.6% to $2.0246.
    • MoonLake Immunotherapeutics (NASDAQ:MLTX) dropped 17.2% to $19.17 after the company reported Q4 financial results.
    • CareMax, Inc. (NASDAQ:CMAX) fell 15.5% to $2.5875.
    • Dingdong (Cayman) Limited (NYSE:DDL) dropped 15.3% to $3.3850.
    • PDD Holdings Inc. (NYSE:PDD) fell 13.4% to $79.60 after the company reported worse-than-expected Q4 revenues and a decrease in revenues from merchandise sales.
    • LivePerson, Inc. (NASDAQ:LPSN) dropped 12.9% to $3.6650.
    • Nikola Corporation (NASDAQ:NKLA) fell 9.4% to $1.5401.

    Now Read This: Top 5 Tech Stocks Which You'll Regret Missing This Quarter

    Get the next $ABR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABR
    $ACER
    $ACRV
    $ALLR

    CompanyDatePrice TargetRatingAnalyst
    Sigma Lithium Corporation
    $SGML
    2/3/2026$14.00Underperform → Neutral
    BofA Securities
    Gossamer Bio Inc.
    $GOSS
    1/28/2026$9.00Overweight
    Barclays
    Sigma Lithium Corporation
    $SGML
    1/23/2026Hold → Buy
    Canaccord Genuity
    Sigma Lithium Corporation
    $SGML
    1/16/2026Buy → Hold
    Canaccord Genuity
    BankUnited Inc.
    $BKU
    1/15/2026$51.00Outperform
    Raymond James
    MoonLake Immunotherapeutics
    $MLTX
    1/15/2026$10.00Neutral → Sell
    Goldman
    MoonLake Immunotherapeutics
    $MLTX
    1/9/2026$24.00Neutral → Buy
    BTIG Research
    Sigma Lithium Corporation
    $SGML
    1/8/2026$13.00Neutral → Underperform
    BofA Securities
    More analyst ratings

    $ABR
    $ACER
    $ACRV
    $ALLR
    SEC Filings

    View All

    Allarity Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Allarity Therapeutics, Inc. (0001860657) (Filer)

    2/19/26 8:00:48 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Arbor Realty Trust filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - ARBOR REALTY TRUST INC (0001253986) (Filer)

    2/17/26 4:43:57 PM ET
    $ABR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SCHEDULE 13G filed by MoonLake Immunotherapeutics

    SCHEDULE 13G - MoonLake Immunotherapeutics (0001821586) (Subject)

    2/17/26 3:01:28 PM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABR
    $ACER
    $ACRV
    $ALLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sigma Lithium upgraded by BofA Securities with a new price target

    BofA Securities upgraded Sigma Lithium from Underperform to Neutral and set a new price target of $14.00

    2/3/26 6:51:05 AM ET
    $SGML
    Metal Mining
    Basic Materials

    Barclays initiated coverage on Gossamer Bio with a new price target

    Barclays initiated coverage of Gossamer Bio with a rating of Overweight and set a new price target of $9.00

    1/28/26 7:16:48 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sigma Lithium upgraded by Canaccord Genuity

    Canaccord Genuity upgraded Sigma Lithium from Hold to Buy

    1/23/26 12:02:57 PM ET
    $SGML
    Metal Mining
    Basic Materials

    $ABR
    $ACER
    $ACRV
    $ALLR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results

    In the Phase 2 S-OLARIS clinical trial in axial spondyloarthritis (axSpA), sonelokimab (SLK) demonstrated clinically meaningful benefit with 80+% of patients achieving ASAS40 by Week 12Consistently, other clinical and imaging scores also showed improvements of 80+% by week 12 for patients treated with SLK, including ASDAS-CRP and SPARCC MRIaxSpA is a disease driven by inflammation leading to irreversible ossification (via osteoblast activity) and ultimately to irreversible restriction of mobility – objective PET/MRI imaging data further showed a significant reduction in inflammation and osteoblast activity deep in affected joints, already by week 12, suggesting potential for disease modifica

    2/22/26 11:00:00 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    OSI Systems Receives ECAC/EU G1 Certification of Trace Detection Solutions for Airport Security

    OSI Systems, Inc. (NASDAQ:OSIS) ("OSI Systems" or the "Company") announced today that its Security division's Itemiser® 4DX and new Itemiser 5X trace detection systems have achieved ECAC/EU G1 approval, meeting the highest European standards for aviation security. This approval reflects compliance with the European Civil Aviation Conference (ECAC) and European Commission requirements for trace detection systems, supporting enhanced security for airline passengers. "Achieving ECAC approval and EU G1 certification demonstrates our commitment to delivering innovative solutions that meet rigorous global security standards and help our customers protect people and assets worldwide," commented

    2/19/26 8:30:00 AM ET
    $OSIS
    Semiconductors
    Technology

    CISO Global Lands 30 Year Sales Veteran Michael Czerneda to Ignite the Next Wave of Software Growth

    New Vice President of Sales to accelerate software-driven growth across cyber services platform and insurance distribution channels  Scottsdale, Ariz., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Michael Czerneda as Vice President of Sales. In this role, Czerneda will lead enterprise-wide sales initiatives as the Company accelerates its transition toward scalable, software-driven growth built on its established cyber services platform.  Czerneda brings more than 30 years of sales leadership experience spanning UCaaS, CCaaS, da

    2/18/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    $ABR
    $ACER
    $ACRV
    $ALLR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for OLPRUVA issued to ACER THERAPEUTICS INC

    Submission status for ACER THERAPEUTICS INC's drug OLPRUVA (ORIG-1) with active ingredient SODIUM PHENYLBUTYRATE has changed to 'Approval' on 12/22/2022. Application Category: NDA, Application Number: 214860, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/23/22 1:58:04 PM ET
    $ACER
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABR
    $ACER
    $ACRV
    $ALLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Dna Holdings Venture Inc. claimed ownership of 223,201 shares (SEC Form 3)

    3 - DNA X, Inc. (0001178697) (Issuer)

    2/20/26 4:30:26 PM ET
    $SONM
    Telecommunications Equipment
    Utilities

    Chief Accounting Officer Peterson Katharine covered exercise/tax liability with 116 shares, decreasing direct ownership by 3% to 4,006 units (SEC Form 4)

    4 - Acrivon Therapeutics, Inc. (0001781174) (Issuer)

    2/18/26 4:14:35 PM ET
    $ACRV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Legal Officer Miller Mary covered exercise/tax liability with 217 shares, decreasing direct ownership by 0.64% to 33,679 units (SEC Form 4)

    4 - Acrivon Therapeutics, Inc. (0001781174) (Issuer)

    2/18/26 4:12:42 PM ET
    $ACRV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABR
    $ACER
    $ACRV
    $ALLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Graves Greg M bought $28,125 worth of shares (220 units at $127.83), increasing direct ownership by 0.56% to 39,541 units (SEC Form 4)

    4 - UMB FINANCIAL CORP (0000101382) (Issuer)

    2/3/26 6:29:24 PM ET
    $UMBF
    Major Banks
    Finance

    Director Peterman Tamara bought $19,687 worth of shares (154 units at $127.83), increasing direct ownership by 2% to 10,102 units (SEC Form 4)

    4 - UMB FINANCIAL CORP (0000101382) (Issuer)

    2/3/26 6:26:17 PM ET
    $UMBF
    Major Banks
    Finance

    President and CEO Blume-Jensen Peter bought $82,124 worth of shares (49,000 units at $1.68) (SEC Form 4)

    4 - Acrivon Therapeutics, Inc. (0001781174) (Issuer)

    1/16/26 4:02:48 PM ET
    $ACRV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABR
    $ACER
    $ACRV
    $ALLR
    Leadership Updates

    Live Leadership Updates

    View All

    CISO Global Lands 30 Year Sales Veteran Michael Czerneda to Ignite the Next Wave of Software Growth

    New Vice President of Sales to accelerate software-driven growth across cyber services platform and insurance distribution channels  Scottsdale, Ariz., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Michael Czerneda as Vice President of Sales. In this role, Czerneda will lead enterprise-wide sales initiatives as the Company accelerates its transition toward scalable, software-driven growth built on its established cyber services platform.  Czerneda brings more than 30 years of sales leadership experience spanning UCaaS, CCaaS, da

    2/18/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    Arbor Realty Trust, Inc. Announces the Appointment of Jeff Lee as its Executive Vice President and Head of Agency Lending

    UNIONDALE, N.Y., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), a real estate investment trust and national direct lender specializing in loan origination and servicing for multifamily, single-family rental (SFR) portfolios, seniors housing, healthcare, and other diverse commercial real estate assets, is pleased to announce the appointment of Jeff Lee, Executive Vice President and Head of Agency Lending. Mr. Lee will oversee and lead Arbor's agency lending platform, including Fannie Mae, Freddie Mac, and FHA products. He will manage all originations, credit, underwriting, capital markets and operational components that support Arbor's agency platforms. Mr. Lee wil

    2/17/26 8:31:00 AM ET
    $ABR
    Real Estate Investment Trusts
    Real Estate

    Arbor Realty Trust, Inc. Announces the Appointment of Yoni Goodman as its Executive Vice President and Chief Operating Officer

    UNIONDALE, N.Y., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE: ABR), a real estate investment trust and national direct lender specializing in loan origination and servicing for multifamily, single-family rental (SFR) portfolios, seniors housing, healthcare, and other diverse commercial real estate assets, is pleased to announce the appointment of Yoni Goodman as its Executive Vice President and Chief Operating Officer. Mr. Goodman will be responsible for expanding Arbor's reach into various segments of the commercial real estate industry, focusing on loan brokerage, strategic acquisitions, and investment fund formation, as well as helping to oversee and grow Arbor's e

    2/17/26 8:30:00 AM ET
    $ABR
    Real Estate Investment Trusts
    Real Estate

    $ABR
    $ACER
    $ACRV
    $ALLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by SuRo Capital Corp.

    SC 13D - SURO CAPITAL CORP. (0001509470) (Subject)

    12/4/24 4:10:31 PM ET
    $SSSS
    Finance: Consumer Services
    Finance

    Amendment: SEC Form SC 13G/A filed by Golden Minerals Company

    SC 13G/A - Golden Minerals Co (0001011509) (Subject)

    11/14/24 7:11:10 PM ET
    $AUMN
    Precious Metals
    Basic Materials

    Amendment: SEC Form SC 13G/A filed by LivePerson Inc.

    SC 13G/A - LIVEPERSON INC (0001102993) (Subject)

    11/14/24 5:21:06 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    $ABR
    $ACER
    $ACRV
    $ALLR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    What Does the Recent Purchase at Air Transport Services Group Inc on Jun 7 Indicate?

    Recently, on June 7, 2024, Michael L Berger, a significant figure at Air Transport Services Group Inc, made a notable insider purchase. Berger bought $49,830 worth of shares, acquiring 3,996 units at a price of $12.47 per share. This transaction increased his direct ownership by 4% to 103,705 units as reported in the SEC Form 4 here. Examining other insider actions within the company can sometimes reveal intriguing patterns that might offer insights for investors. Looking back at previous transactions, we see a series of insider activities at Air Transport Services Group Inc: In March 2024, Dominick Jeffrey A. filed an SEC Form 4, indicating a notable transaction date in which actions were

    6/10/24 12:35:45 AM ET
    $GNLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABR
    $ACER
    $ACRV
    $ALLR
    Financials

    Live finance-specific insights

    View All

    SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026

    BOSTON and ROLLE, Switzerland, Feb. 17, 2026 /PRNewswire/ -- SOPHiA GENETICS (NASDAQ:SOPH), a global leader in AI-driven precision medicine, today announced it will release its financial results for the fourth quarter and full year 2025 before U.S. markets open on Tuesday, March 3, 2026. On that day, SOPHiA GENETICS will host a conference call to discuss its financial results as well as business outlook beginning at 8:00 a.m. (08:00) EDT / 2:00 p.m. (14:00) CET. The call will be webcast live on the SOPHiA GENETICS Investor Relations Website. Additionally, a replay will be availa

    2/17/26 8:00:00 AM ET
    $SOPH
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Dingdong Announces Intention to Utilize Substantial Majority of Proceeds from Sale of China Operations for Share Repurchase Plans and/or Dividends upon Closing of Transaction

    SHANGHAI, Feb. 10, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong Cayman" or the "Company") (NYSE:DDL), a leading fresh grocery e-commerce company in China, today announced that it intends to utilize a substantial majority of the cash proceeds from the sale of its China operations upon the closing of such Transaction (as defined below) for share repurchases or the issuance of dividends to its shareholders. As previously disclosed on February 5, 2026, the Company entered into a definitive Share Purchase Agreement (the "Share Purchase Agreement") with Two Hearts Investments Limited ("Buyer"), a wholly-owned subsidiary of Meituan (HKEX: 3690). Pursuant to the Share Purchase Agreemen

    2/10/26 8:00:00 AM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary

    Arbor Realty Trust Schedules Fourth Quarter 2025 Earnings Conference Call

    UNIONDALE, N.Y., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Arbor Realty Trust, Inc. (NYSE:ABR), today announced that it is scheduled to release fourth quarter 2025 financial results before the market opens on Friday, February 27, 2026. The Company will host a conference call to review the results at 10:00 a.m. Eastern Time on February 27, 2026. A live webcast and replay of the conference call will be available at www.arbor.com in the investor relations section of the Company's website. Those without web access should access the call telephonically at least ten minutes prior to the conference call. The dial-in numbers are (800) 267-6316 for domestic callers and (203) 518-9783 for international cal

    2/6/26 4:51:53 PM ET
    $ABR
    Real Estate Investment Trusts
    Real Estate